_version_ 1785090430427201536
author Litzow, Mark
Sun, Zhuoxin
Mattison, Ryan
Paietta, Elisabeth
Mullighan, Charles
Roberts, Kathryn
Zhang, Yanming
Racevskis, Janis
Willman, Cheryl
Wieduwilt, Matthew
Liedtke, Michaela
Bergeron, Julie
Lazarus, Hillard
Arber, Dan
Wood, Brent
Rowe, Jacob
Pratz, Keith
Dinner, Shira
Frey, Noelle
Gore, Steve
Bhatnagar, Bhavana
Atallah, Ehab
Uy, Geoff
Jeyakumar, Deepa
Lin, Tara
Patel, Shejal
Elliott, Michelle
Advani, Anjali
Deangelo, Daniel
Tzachanis, Dimitrios
Vachhani, Pankit
Bhave, Rupali
Little, Richard
Erba, Harry
Stone, Richard
Luger, Selina
Tallman, Martin
author_facet Litzow, Mark
Sun, Zhuoxin
Mattison, Ryan
Paietta, Elisabeth
Mullighan, Charles
Roberts, Kathryn
Zhang, Yanming
Racevskis, Janis
Willman, Cheryl
Wieduwilt, Matthew
Liedtke, Michaela
Bergeron, Julie
Lazarus, Hillard
Arber, Dan
Wood, Brent
Rowe, Jacob
Pratz, Keith
Dinner, Shira
Frey, Noelle
Gore, Steve
Bhatnagar, Bhavana
Atallah, Ehab
Uy, Geoff
Jeyakumar, Deepa
Lin, Tara
Patel, Shejal
Elliott, Michelle
Advani, Anjali
Deangelo, Daniel
Tzachanis, Dimitrios
Vachhani, Pankit
Bhave, Rupali
Little, Richard
Erba, Harry
Stone, Richard
Luger, Selina
Tallman, Martin
author_sort Litzow, Mark
collection PubMed
description
format Online
Article
Text
id pubmed-10428281
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104282812023-08-17 S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910 Litzow, Mark Sun, Zhuoxin Mattison, Ryan Paietta, Elisabeth Mullighan, Charles Roberts, Kathryn Zhang, Yanming Racevskis, Janis Willman, Cheryl Wieduwilt, Matthew Liedtke, Michaela Bergeron, Julie Lazarus, Hillard Arber, Dan Wood, Brent Rowe, Jacob Pratz, Keith Dinner, Shira Frey, Noelle Gore, Steve Bhatnagar, Bhavana Atallah, Ehab Uy, Geoff Jeyakumar, Deepa Lin, Tara Patel, Shejal Elliott, Michelle Advani, Anjali Deangelo, Daniel Tzachanis, Dimitrios Vachhani, Pankit Bhave, Rupali Little, Richard Erba, Harry Stone, Richard Luger, Selina Tallman, Martin Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428281/ http://dx.doi.org/10.1097/01.HS9.0000967372.19440.62 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Oral Sessions
Litzow, Mark
Sun, Zhuoxin
Mattison, Ryan
Paietta, Elisabeth
Mullighan, Charles
Roberts, Kathryn
Zhang, Yanming
Racevskis, Janis
Willman, Cheryl
Wieduwilt, Matthew
Liedtke, Michaela
Bergeron, Julie
Lazarus, Hillard
Arber, Dan
Wood, Brent
Rowe, Jacob
Pratz, Keith
Dinner, Shira
Frey, Noelle
Gore, Steve
Bhatnagar, Bhavana
Atallah, Ehab
Uy, Geoff
Jeyakumar, Deepa
Lin, Tara
Patel, Shejal
Elliott, Michelle
Advani, Anjali
Deangelo, Daniel
Tzachanis, Dimitrios
Vachhani, Pankit
Bhave, Rupali
Little, Richard
Erba, Harry
Stone, Richard
Luger, Selina
Tallman, Martin
S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910
title S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910
title_full S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910
title_fullStr S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910
title_full_unstemmed S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910
title_short S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910
title_sort s115: consolidation with blinatumomab improves overall and relapse-free survival in patients with newly diagnosed b-cell acute lymphoblastic leukemia: impact of age and mrd level in ecog-acrin e1910
topic Oral Sessions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428281/
http://dx.doi.org/10.1097/01.HS9.0000967372.19440.62
work_keys_str_mv AT litzowmark s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT sunzhuoxin s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT mattisonryan s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT paiettaelisabeth s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT mullighancharles s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT robertskathryn s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT zhangyanming s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT racevskisjanis s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT willmancheryl s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT wieduwiltmatthew s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT liedtkemichaela s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT bergeronjulie s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT lazarushillard s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT arberdan s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT woodbrent s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT rowejacob s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT pratzkeith s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT dinnershira s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT freynoelle s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT goresteve s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT bhatnagarbhavana s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT atallahehab s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT uygeoff s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT jeyakumardeepa s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT lintara s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT patelshejal s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT elliottmichelle s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT advanianjali s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT deangelodaniel s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT tzachanisdimitrios s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT vachhanipankit s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT bhaverupali s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT littlerichard s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT erbaharry s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT stonerichard s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT lugerselina s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910
AT tallmanmartin s115consolidationwithblinatumomabimprovesoverallandrelapsefreesurvivalinpatientswithnewlydiagnosedbcellacutelymphoblasticleukemiaimpactofageandmrdlevelinecogacrine1910